Tristetraprolin regulates the decay of the hypoxia-induced vascular endothelial growth factor mRNA in ARPE-19 cells

Citations

WEB OF SCIENCE

4
Citations

SCOPUS

4

초록

The aim of the present study was to investigate the effects of tristetraprolin (TTP) on the vascular endothelial growth factor (VEGF) mRNA and protein expression levels in retinal pigment epithelial cells under hypoxic conditions, and to consider the possibility of using TTP as a novel treatment tool for neovascular age-related macular degeneration (AMD). Overexpression of TTP reduced the expression and secretion levels of VEGF in ARPE-19 cells under hypoxic conditions. TTP destabilized the VEGF mRNA by binding to adenosine and uridine-rich elements regions in its 3'-untranslated region. Furthermore, conditioned medium (CM) from TTP-overexpressing ARPE-19 cells suppressed the tube formation in human umbilical vein endothelial cells compared with hypoxic CM. These findings indicate that regulation of TTP expression may be a promising therapeutic tool for neovascular AMD, however, further research is required.

키워드

ARPE-19 cellshypoxianeovascular age-related macular degenerationtristetraprolinvascular endothelial growth factorHUMAN COLON-CANCERANTI-VEGF THERAPYMACULAR DEGENERATIONPLASMINOGEN-ACTIVATORUNTRANSLATED REGIONRANIBIZUMABEXPRESSIONSTABILITYAFLIBERCEPTGENE
제목
Tristetraprolin regulates the decay of the hypoxia-induced vascular endothelial growth factor mRNA in ARPE-19 cells
저자
Ryu, JinhyunSeong, HyeminYoon, NalaeSeo, Seong WookPark, Jeong WooKang, Sang SooPark, Jong MoonHan, Yong Seop
DOI
10.3892/mmr.2016.5890
발행일
2016-12
유형
Article
저널명
Molecular Medicine Reports
14
6
페이지
5395 ~ 5400